LIVN (LivaNova) FFO


LIVN LivaNova PLC LIVN
76 GF Score
Price $81.05
GF Value $62.48
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova FFO?

FFO (Funds from operations) only applies to REITs.

LIVN
76GF Score
LivaNova PLC LIVN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is LivaNova (LIVN) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of $81.05 is trading 29.7% above its estimated GF Value™ of $62.48. GuruFocus considers LivaNova to be Modestly Overvalued.

Key valuation signals for LIVN:

  • FFO:
  • GF Value™: $62.48 vs. price of $81.05 (29.7% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the LIVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LivaNova Business Description

Other Exchanges LIA:Germany
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
76GF Score

Get the complete analysis for LIVN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.05
Price
$62.48
GF Value